Andrew Sanderson

Associate

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Andy read applied microbiology at the University of Nottingham, before teaching secondary-level science overseas. Upon returning to the UK he undertook a PhD in Molecular Microbiology at the Institute of Infection, Immunity and Inflammation (University of Nottingham).

During his doctorate, Andy was seconded to the Department of Molecular Biology of Umeå University, Sweden for several months. His research concerned the identification of a bacterial RNA-binding protein and its cognate regulatory RNA's, along with exploration of their role in density-dependent gene regulation.

Andy joined Potter Clarkson in 2006 and specialises in biotechnology and biomedical patenting matters.

News & Publications

Date	News Infomation
Nov 07 2011	CJEU DECISION ON THE PATENTABILITY OF HUMAN EMBRYONIC STEM CELL LINES Taking away with one hand, giving with the other? Background: stem cell research, controversy and the law Stem cells are able to differentiate into specialised cell types and therefore have great potential as tools for therapeutic tissue and organ regeneration. As a result, they are the focus of a considerable amount of academic and industrial research.

Date

News Infomation

Nov

2011

CJEU DECISION ON THE PATENTABILITY OF HUMAN EMBRYONIC STEM CELL LINES

Taking away with one hand, giving with the other?

Background: stem cell research, controversy and the law

Stem cells are able to differentiate into specialised cell types and therefore have great potential as tools for therapeutic tissue and organ regeneration. As a result, they are the focus of a considerable amount of academic and industrial research.